José Courty
José Courty
Email verificata su
Citata da
Citata da
Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth …
RA Dean, GS Butler, Y Hamma-Kourbali, J Delbé, DR Brigstock, J Courty, ...
Molecular and cellular biology 27 (24), 8454-8465, 2007
Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery
S Kossatz, J Grandke, P Couleaud, A Latorre, A Aires, ...
Breast Cancer Research 17 (1), 66, 2015
Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin
D Destouches, D El Khoury, Y Hamma-Kourbali, B Krust, P Albanese, ...
PloS one 3 (6), e2518, 2008
Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin
J Courty, MC Dauchel, D Caruelle, M Perderiset, D Barritault
Biochemical and biophysical research communications 180 (1), 145-151, 1991
A unique family of endothelial cell polypeptide mitogens: the antigenic and receptor cross-reactivity of bovine endothelial cell growth factor, brain-derived acidic fibroblast …
AB Schreiber, J Kenney, J Kowalski, KA Thomas, G Gimenez-Gallego, ...
The Journal of cell biology 101 (4), 1623-1626, 1985
Bovine retina contains three growth factor activities with different affinity to heparin: eye derived growth factor I, II, III
J Courty, C Loret, M Moenner, B Chevallier, O Lagente, Y Courtois, ...
Biochimie 67 (2), 265-269, 1985
Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide
K Laaroubi, J Delbe, F Vacherot, P Desgranges, M Tardieu, M Jaye, ...
Growth Factors 10 (2), 89-98, 1994
Angiogenesis analyzer for ImageJ
G Carpentier, M Martinelli, J Courty, I Cascone
4th ImageJ User and Developer Conference proceedings, 198-201, 2012
Purification, characterization, and biological properties of the eye‐derived growth factor from retina: Analogies with brain‐derived growth factor
D Barritault, J Plouët, J Courty, Y Courtois
Journal of neuroscience research 8 (2‐3), 477-490, 1982
Pleiotrophin inhibits HIV infection by binding the cell surface‐expressed nucleolin
EA Said, J Courty, J Svab, J Delbé, B Krust, AG Hovanessian
The FEBS journal 272 (18), 4646-4659, 2005
Characterization of heparin affin regulatory peptide signaling in human endothelial cells
A Polykratis, P Katsoris, J Courty, E Papadimitriou
Journal of Biological Chemistry 280 (23), 22454-22461, 2005
Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis
M Heroult, I Bernard-Pierrot, J Delbe, Y Hamma-Kourbali, P Katsoris, ...
Oncogene 23 (9), 1745-1753, 2004
A synthetic glycosaminoglycan mimetic binds vascular endothelial growth factor and modulates angiogenesis
V Rouet, Y Hamma-Kourbali, E Petit, P Panagopoulou, P Katsoris, ...
Journal of Biological Chemistry 280 (38), 32792-32800, 2005
Identification of heparin-binding sites in proteins by selective labeling
A Ori, P Free, J Courty, MC Wilkinson, DG Fernig
Molecular & Cellular Proteomics 8 (10), 2256-2265, 2009
Comparison of the effects of EGF, pFGF and EDGF on corneal epithelium wound healing
G Petroutsos, J Courty, R Guimaraes, Y Pouliquen, D Barritault, J Plouet, ...
Current eye research 3 (4), 593-598, 1984
HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides
E Papadimitriou, A Polykratis, J Courty, P Koolwijk, M Heroult, P Katsoris
Biochemical and biophysical research communications 282 (1), 306-313, 2001
A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins
D Destouches, N Page, Y Hamma-Kourbali, V Machi, O Chaloin, ...
Cancer research 71 (9), 3296-3305, 2011
The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities
I Bernard-Pierrot, J Delbé, D Caruelle, D Barritault, J Courty, PE Milhiet
Journal of Biological Chemistry 276 (15), 12228-12234, 2001
Glycosaminoglycans differentially bind HARP and modulate its biological activity
F Vacherot, J Delbé, M Heroult, D Barritault, DG Fernig, J Courty
Journal of Biological Chemistry 274 (12), 7741-7747, 1999
Dominant-stable β-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model
D Boerboom, LD White, S Dalle, J Courty, JAS Richards
Cancer research 66 (4), 1964-1973, 2006
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20